Condition
Paget Disease
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Enrolling By Invitation1
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03859895Enrolling By InvitationPrimary
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
NCT05309954Active Not RecruitingPrimary
Genetic Analysis to Predict the Development of Paget's Disease
NCT03438123Not ApplicableCompleted
Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera
Showing all 3 trials